{"denomUnitsSelected":"Participants","description":"A binary variable will be determined for each participant indicating whether or not the subject discontinued study treatment due to adverse events.","reportingStatus":"NOT_POSTED","timeFrame":"From enrollment to 30 days following cessation of study treatment. Reasons for study treatment discontinuation include progression, toxicity, consent withdrawal, or investigator decision; assessed for approximately 5 years.","title":"Number of Participants Who Discontinued Study Treatment Due to Adverse Events","type":"OTHER_PRE_SPECIFIED"}